Deucravacitinib

CHEMBL4435170 Phase 4 अनुमोदित Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

425.5 g/mol

LogP

1.2

Phase

4

A targeted oral medication that selectively inhibits TYK2, an enzyme involved in immune signaling pathways that drive inflammatory diseases. It is used to treat psoriasis and is being studied for other inflammatory conditions.

आणविक भार

425.5000 g/mol

LogP

1.20

TPSA

136.00 Å²

लिपिंस्की RO5

उत्तीर्ण

चिकित्सीय क्षेत्र

इंफ्लेमेटरी बाउल डिज़ीज़ एटोपिक डर्मेटाइटिस (एक्जिमा) प्रोस्टेट कैंसर सिस्टेमिक ल्यूपस एरिथेमेटोसस सोरायसिस

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D संरचना

SVG PNG

Cite this structure

Embed this structure

SMILES

[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC

InChI

InChI=1S/C20H22N8O3/c1-21-20(30)16-14(9-15(25-26-16)24-19(29)11-7-8-11)23-13-6-4-5-12(17(13)31-3)18-22-10-28(2)27-18/h4-6,9-11H,7-8H2,1-3H3,(H,21,30)(H2,23,24,25,29)/i1D3

Molecular Formula

C20H22N8O3

HBD / HBA

3 / 8

घूर्णनीय बंधन

7

भारी परमाणु

31

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

अक्सर पूछे जाने वाले प्रश्न

A targeted oral medication that selectively inhibits TYK2, an enzyme involved in immune signaling pathways that drive inflammatory diseases. It is used to treat psoriasis and is being studied for other inflammatory conditions.

Yes, Deucravacitinib is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4435170. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 134821691. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

रोगी-अनुकूल जानकारी खोज रहे हैं?

Deucravacitinib PillFYI पर

संरचना

त्वरित डेटा

सूत्र: C20H22N8O3
पर्यायवाची: 1

बाहरी लिंक

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

चिकित्सा अस्वीकरण

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.